Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Cash flows from operating activities:
Net (loss) income	$ 10,941	$ 62,444
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization expense	36,002	43,688
Amortization of debt costs	14,583	9,893
Stock-based compensation	5,102	6,025
Long-lived asset impairments	14,556	23,217
Gains on refranchising	(276)	(314)
Loss on debt refinancing	16,740	0
Third-party fees associated with refinancing	(16,322)	0
Changes in assets and liabilities:
(Increase) decrease in receivables	(6,080)	1,204
(Increase) decrease in inventory	(5,794)	45,753
Increase in prepaid and other current assets	(6,552)	(5,205)
Increase (decrease) in accounts payable	6,860	(19,732)
Decrease in deferred revenue and accrued liabilities	(10,565)	(19,891)
Other operating activities	(3,506)	2,486
Net cash provided by operating activities	55,689	149,568
Cash flows from investing activities:
Capital expenditures	(13,355)	(26,210)
Refranchising proceeds	2,136	3,410
Store acquisition costs	(220)	(1,930)
Net cash used in investing activities	(11,439)	(24,730)
Cash flows from financing activities:
Borrowings under revolving credit facility	261,500	177,500
Payments on revolving credit facility	(261,500)	(256,500)
Original Issuance Discount and revolving credit facility fees	(35,235)	0
Deferred fees associated with pending equity transaction	(3,443)	0
Minimum tax withholding requirements	(296)	(252)
Net cash used in financing activities	(74,487)	(120,105)
Effect of exchange rate changes on cash and cash equivalents	(416)	921
Net (decrease) increase in cash and cash equivalents	(30,653)	5,654
Beginning balance, cash and cash equivalents	64,001	34,464
Ending balance, cash and cash equivalents	33,348	40,118
Non-cash investing activities:
Capital expenditures in current liabilities	1,177	2,141
Receivable related to the sale of Lucky Vitamin	0	7,117
Non-cash financing activities:
Original issuance discount	13,231	0
Tranche B-1
Cash flows from financing activities:
Payments on term loan facility	(3,413)	(40,853)
Tranche B-2
Cash flows from financing activities:
Payments on term loan facility	$ (32,100)	$ 0